Related Experiment Video
Updated: May 24, 2026

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
Published on: November 15, 2024
Diabetes, hyperglycaemia, and acute ischaemic stroke
Merel J A Luitse1, Geert Jan Biessels, Guy E H M Rutten
1Department of Neurology, University Medical Centre Utrecht Stroke Centre and Rudolf Magnus Institute of Neuroscience, UMC Utrecht, Utrecht, Netherlands.
Insights
Diabetes significantly increases ischaemic stroke risk. Managing blood sugar (hyperglycaemia) in acute stroke patients is challenging but may improve outcomes, though research is ongoing.
Area of Science:
- Neurology
- Endocrinology
- Cardiovascular Medicine
Background:
- Diabetes mellitus is a major risk factor for ischaemic stroke, more than doubling risk.
- Hyperglycaemia is prevalent in acute ischaemic stroke patients, even those without diagnosed diabetes.
- Admission hyperglycaemia correlates with poorer functional outcomes post-stroke.
Purpose of the Study:
- To explore the link between diabetes, hyperglycaemia, and ischaemic stroke.
- To discuss the implications of managing hyperglycaemia in acute ischaemic stroke.
- To review the current understanding and ongoing research into glucose-lowering therapies for stroke.
Main Methods:
- Review of existing literature on diabetes, stroke, and hyperglycaemia.
- Analysis of the association between admission glucose levels and stroke outcomes.
- Discussion of challenges and potential benefits of glucose-lowering interventions.
Main Results:
- Individuals with diabetes have a significantly elevated risk of ischaemic stroke.
- Hyperglycaemia upon admission is linked to worse outcomes in acute ischaemic stroke.
- The efficacy of early glucose-lowering treatment in acute stroke remains uncertain.
Conclusions:
- Multifactorial risk factor management, including lifestyle, hypertension, and dyslipidaemia, is crucial for stroke prevention in diabetics.
- Achieving normoglycaemia in acute stroke is difficult and carries risks like hypoglycaemia.
- Further research, including Phase 3 trials, is needed to determine the role of glucose-lowering therapy in acute ischaemic stroke.
Abstract:
Diabetes and ischaemic stroke often arise together. People with diabetes have more than double the risk of ischaemic stroke after correction for other risk factors, relative to individuals without diabetes. Multifactorial treatment of risk factors for stroke-in particular, lifestyle factors, hypertension, and dyslipidaemia-will prevent a substantial number of these disabling strokes. Hyperglycaemia occurs in 30-40% of patients with acute ischaemic stroke, also in individuals without a known history of diabetes. Admission hyperglycaemia is associated with poor functional outcome, possibly through aggravation of ischaemic damage by disturbing recanalisation and increasing reperfusion injury. Uncertainty surrounds the question of whether glucose-lowering treatment for early stroke can improve clinical outcome. Achievement of normoglycaemia in the early stage of stroke can be difficult, and the possibility of hypoglycaemia remains a concern. Phase 3 studies of glucose-lowering therapy in acute ischaemic stroke are underway.
Related Concept Videos
Complications of Diabetes Mellitus
Hyperglycemia
Diabetic Retinopathy
Hypoglycemia
Ischemic Stroke l: Introduction
Diabetes: Symptoms, Diagnosis, and Complications